312
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Underutilization of statins in patients with type 2 diabetes in US clinical practice: a retrospective cohort study

, , , , &
Pages 1035-1040 | Accepted 25 Feb 2011, Published online: 16 Mar 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Grigorios Rombopoulos, Elena Panitti, Christos Varounis, Christos Katsinas, Ioannis Stefanidis & Dimitrios Goumenos. (2016) A multicenter, epidemiological study of the treatment patterns, comorbidities and hypoglycemia events of patients with type 2 diabetes and moderate or severe chronic kidney disease – the ‘LEARN’ study. Current Medical Research and Opinion 32:5, pages 939-947.
Read now
Peter Sun, Kaan Tunceli, Qiaoyi Zhang, Thomas Seck, Kristy Iglay, Michael J. Davies, Baishali Ambegaonkar & Larry Radican. (2013) Time to initiation of oral antihyperglycemic and statin therapy in previously untreated patients with type 2 diabetes in the United States. Current Medical Research and Opinion 29:7, pages 801-806.
Read now

Articles from other publishers (11)

Mohammed B. Ayalew, Gudrun Dieberg, Frances Quirk & Marion J. Spark. (2022) Assessment of Potentially Inappropriate Prescribing for People With Type 2 Diabetes Mellitus Using IMPACT2DM, a New Explicit Tool. Journal of Pharmacy Practice, pages 089719002211452.
Crossref
Nimish N. Shah, Lama Ghazi, Yu Yamamoto, Melissa Martin, Michael Simonov, Ralph J. Riello, Kamil F. Faridi, Tariq Ahmad, F. Perry Wilson & Nihar R. Desai. (2022) Rationale and design of a pragmatic trial aimed at improving treatment of hyperlipidemia in outpatients with very high risk atherosclerotic cardiovascular disease: A pragmatic trial of messaging to providers about treatment of hyperlipidemia (PROMPT-LIPID). American Heart Journal 253, pages 76-85.
Crossref
Mohammed Biset Ayalew, M. Joy Spark, Frances Quirk & Gudrun Dieberg. (2022) Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review. International Journal of Clinical Pharmacy 44:4, pages 860-872.
Crossref
Féaron C. Cassidy, Sinead Lafferty & Cynthia M. Coleman. 2021. Type 2 Diabetes - From Pathophysiology to Cyber Systems. Type 2 Diabetes - From Pathophysiology to Cyber Systems.
John A Ambrose & Amir Najafi. (2018) Strategies for the Prevention of Coronary Artery Disease Complications: Can We Do Better?. The American Journal of Medicine 131:9, pages 1003-1009.
Crossref
Iris Lin, Jennifer Sung, Robert J. Sanchez, Usha G. Mallya, Mark Friedman, Mary Panaccio, Andrew Koren, Peter Neumann & Joseph Menzin. (2016) Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk. Journal of Managed Care & Specialty Pharmacy 22:6, pages 685-698.
Crossref
Z. Kevin Lu, Minghui Li, Whitney D. Maxwell & Richard M. Schulz. (2016) Implementation of the American Diabetes Association's Standards of Medical Care post-Medicare Part D: The case of statin utilization in the elderly with diabetes. Research in Social and Administrative Pharmacy 12:3, pages 419-427.
Crossref
Emma E. McGinty, Julia Baller, Susan T. Azrin, Denise Juliano-Bult & Gail L. Daumit. (2015) Quality of medical care for persons with serious mental illness: A comprehensive review. Schizophrenia Research 165:2-3, pages 227-235.
Crossref
Brian Bryzinski, Elsie Allen, William Cook & Boaz Hirshberg. (2014) Saxagliptin efficacy and safety in patients with type 2 diabetes receiving concomitant statin therapy. Journal of Diabetes and its Complications 28:6, pages 887-893.
Crossref
Barbara Daly, Timothy Kenealy, Bruce Arroll, Nicolette Sheridan & Robert Scragg. (2014) Do primary health care nurses address cardiovascular risk in diabetes patients?. Diabetes Research and Clinical Practice 106:2, pages 212-220.
Crossref
Heike U Krämer, Elke Raum, Gernot Rüter, Ben Schöttker, Dietrich Rothenbacher, Thomas Rosemann, Joachim Szecsenyi & Hermann Brenner. (2012) Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study. Cardiovascular Diabetology 11:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.